TY - JOUR
T1 - Blepharophimosis with intellectual disability and Helsmoortel-Van Der Aa Syndrome share episignature and phenotype
AU - Sarli, Camilla
AU - van der Laan, Liselot
AU - Reilly, Jack
AU - Trajkova, Slavica
AU - Carli, Diana
AU - Brusco, Alfredo
AU - Levy, Michael A
AU - Relator, Raissa
AU - Kerkhof, Jennifer
AU - McConkey, Haley
AU - Tedder, Matthew L
AU - Skinner, Cindy
AU - Alders, Marielle
AU - Henneman, Peter
AU - Hennekam, Raoul C M
AU - Ciaccio, Claudia
AU - D'Arrigo, Stefano
AU - Vitobello, Antonio
AU - Faivre, Laurence
AU - Weber, Sacha
AU - Vincent-Devulder, Aline
AU - Perrin, Laurence
AU - Bourgois, Alexia
AU - Yamamoto, Toshiyuki
AU - Metcalfe, Kay
AU - Zollino, Marcella
AU - Kini, Usha
AU - Oliveira, Daniela
AU - Sousa, Sérgio B.
AU - Williams, Denise
AU - Cappuccio, Gerarda
AU - Sadiković, Bekim
AU - Brunetti-Pierri, Nicola
N1 - Publisher Copyright:
© 2024 The Author(s). American Journal of Medical Genetics Part C: Seminars in Medical Genetics published by Wiley Periodicals LLC.
PY - 2024/7/24
Y1 - 2024/7/24
N2 - Blepharophimosis with intellectual disability (BIS) is a recently recognized disorder distinct from Nicolaides-Baraister syndrome that presents with distinct facial features of blepharophimosis, developmental delay, and intellectual disability. BIS is caused by pathogenic variants in SMARCA2, that encodes the catalytic subunit of the superfamily II helicase group of the BRG1 and BRM-associated factors (BAF) forming the BAF complex, a chromatin remodeling complex involved in transcriptional regulation. Individuals bearing variants within the bipartite nuclear localization (BNL) signal domain of ADNP present with the neurodevelopmental disorder known as Helsmoortel-Van Der Aa Syndrome (HVDAS). Distinct DNA methylation profiles referred to as episignatures have been reported in HVDAS and BAF complex disorders. Due to molecular interactions between ADNP and BAF complex, and an overlapping craniofacial phenotype with narrowing of the palpebral fissures in a subset of patients with HVDAS and BIS, we hypothesized the possibility of a common phenotype-specific episignature. A distinct episignature was shared by 15 individuals with BIS-causing SMARCA2 pathogenic variants and 12 individuals with class II HVDAS caused by truncating pathogenic ADNP variants. This represents first evidence of a sensitive phenotype-specific episignature biomarker shared across distinct genetic conditions that also exhibit unique gene-specific episignatures.
AB - Blepharophimosis with intellectual disability (BIS) is a recently recognized disorder distinct from Nicolaides-Baraister syndrome that presents with distinct facial features of blepharophimosis, developmental delay, and intellectual disability. BIS is caused by pathogenic variants in SMARCA2, that encodes the catalytic subunit of the superfamily II helicase group of the BRG1 and BRM-associated factors (BAF) forming the BAF complex, a chromatin remodeling complex involved in transcriptional regulation. Individuals bearing variants within the bipartite nuclear localization (BNL) signal domain of ADNP present with the neurodevelopmental disorder known as Helsmoortel-Van Der Aa Syndrome (HVDAS). Distinct DNA methylation profiles referred to as episignatures have been reported in HVDAS and BAF complex disorders. Due to molecular interactions between ADNP and BAF complex, and an overlapping craniofacial phenotype with narrowing of the palpebral fissures in a subset of patients with HVDAS and BIS, we hypothesized the possibility of a common phenotype-specific episignature. A distinct episignature was shared by 15 individuals with BIS-causing SMARCA2 pathogenic variants and 12 individuals with class II HVDAS caused by truncating pathogenic ADNP variants. This represents first evidence of a sensitive phenotype-specific episignature biomarker shared across distinct genetic conditions that also exhibit unique gene-specific episignatures.
KW - ADNP
KW - Helsmoortel-Van Der Aa Syndrome
KW - SMARCA2
KW - blepharophimosis with intellectual disability
U2 - 10.1002/ajmg.c.32089
DO - 10.1002/ajmg.c.32089
M3 - Article
SN - 1552-4868
VL - 196
JO - American Journal of Medical Genetics. Part C, Seminars in Medical Genetics
JF - American Journal of Medical Genetics. Part C, Seminars in Medical Genetics
IS - 4
M1 - e32089
ER -